185 related articles for article (PubMed ID: 17476480)
21. Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?
Gouzoulis-Mayfrank E; Daumann J
Addiction; 2006 Mar; 101(3):348-61. PubMed ID: 16499508
[TBL] [Abstract][Full Text] [Related]
22. The effects of stereotype threat on cognitive function in ecstasy users.
Cole JC; Michailidou K; Jerome L; Sumnall HR
J Psychopharmacol; 2006 Jul; 20(4):518-25. PubMed ID: 16174670
[TBL] [Abstract][Full Text] [Related]
23. Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.
Parrott AC; Lasky J
Psychopharmacology (Berl); 1998 Oct; 139(3):261-8. PubMed ID: 9784083
[TBL] [Abstract][Full Text] [Related]
24. Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs.
Halpern JH; Sherwood AR; Hudson JI; Gruber S; Kozin D; Pope HG
Addiction; 2011 Apr; 106(4):777-86. PubMed ID: 21205042
[TBL] [Abstract][Full Text] [Related]
25. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
[TBL] [Abstract][Full Text] [Related]
26. Altered response to tryptophan supplementation after long-term abstention from MDMA (ecstasy) is highly correlated with human memory function.
Curran HV; Verheyden SL
Psychopharmacology (Berl); 2003 Aug; 169(1):91-103. PubMed ID: 12759801
[TBL] [Abstract][Full Text] [Related]
27. Preliminary evidence of hippocampal dysfunction in adolescent MDMA ("ecstasy") users: possible relationship to neurotoxic effects.
Jacobsen LK; Mencl WE; Pugh KR; Skudlarski P; Krystal JH
Psychopharmacology (Berl); 2004 May; 173(3-4):383-90. PubMed ID: 14647960
[TBL] [Abstract][Full Text] [Related]
28. The neuropsychology of ecstasy (MDMA) use: a quantitative review.
Zakzanis KK; Campbell Z; Jovanovski D
Hum Psychopharmacol; 2007 Oct; 22(7):427-35. PubMed ID: 17896346
[TBL] [Abstract][Full Text] [Related]
29. Memory deficits associated with recreational use of "ecstasy" (MDMA).
Morgan MJ
Psychopharmacology (Berl); 1999 Jan; 141(1):30-6. PubMed ID: 9952062
[TBL] [Abstract][Full Text] [Related]
30. Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use.
Gouzoulis-Mayfrank E; Fischermann T; Rezk M; Thimm B; Hensen G; Daumann J
Drug Alcohol Depend; 2005 Jun; 78(3):317-23. PubMed ID: 15893163
[TBL] [Abstract][Full Text] [Related]
31. Long-term effects of 'ecstasy' abuse on the human brain studied by FDG PET.
Buchert R; Obrocki J; Thomasius R; Väterlein O; Petersen K; Jenicke L; Bohuslavizki KH; Clausen M
Nucl Med Commun; 2001 Aug; 22(8):889-97. PubMed ID: 11473208
[TBL] [Abstract][Full Text] [Related]
32. Auditory event-related potentials (P3) and cognitive performance in recreational ecstasy polydrug users: evidence from a 12-month longitudinal study.
de Sola S; Tarancón T; Peña-Casanova J; Espadaler JM; Langohr K; Poudevida S; Farré M; Verdejo-García A; de la Torre R
Psychopharmacology (Berl); 2008 Oct; 200(3):425-37. PubMed ID: 18581098
[TBL] [Abstract][Full Text] [Related]
33. Neuropsychological function in ecstasy users: a study controlling for polydrug use.
Roiser JP; Rogers RD; Sahakian BJ
Psychopharmacology (Berl); 2007 Jan; 189(4):505-16. PubMed ID: 16163532
[TBL] [Abstract][Full Text] [Related]
34. Memory-related hippocampal functioning in ecstasy and amphetamine users: a prospective fMRI study.
Becker B; Wagner D; Koester P; Bender K; Kabbasch C; Gouzoulis-Mayfrank E; Daumann J
Psychopharmacology (Berl); 2013 Feb; 225(4):923-34. PubMed ID: 23001254
[TBL] [Abstract][Full Text] [Related]
35. The harmful health effects of recreational ecstasy: a systematic review of observational evidence.
Rogers G; Elston J; Garside R; Roome C; Taylor R; Younger P; Zawada A; Somerville M
Health Technol Assess; 2009 Jan; 13(6):iii-iv, ix-xii, 1-315. PubMed ID: 19195429
[TBL] [Abstract][Full Text] [Related]
36. Reduced memory skills and increased hair cortisol levels in recent Ecstasy/MDMA users: significant but independent neurocognitive and neurohormonal deficits.
Downey LA; Sands H; Jones L; Clow A; Evans P; Stalder T; Parrott AC
Hum Psychopharmacol; 2015 May; 30(3):199-207. PubMed ID: 25900184
[TBL] [Abstract][Full Text] [Related]
37. Everyday memory deficits in ecstasy-polydrug users.
Montgomery C; Fisk JE
J Psychopharmacol; 2007 Sep; 21(7):709-17. PubMed ID: 17606476
[TBL] [Abstract][Full Text] [Related]
38. Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study.
Kish SJ; Lerch J; Furukawa Y; Tong J; McCluskey T; Wilkins D; Houle S; Meyer J; Mundo E; Wilson AA; Rusjan PM; Saint-Cyr JA; Guttman M; Collins DL; Shapiro C; Warsh JJ; Boileau I
Brain; 2010 Jun; 133(Pt 6):1779-97. PubMed ID: 20483717
[TBL] [Abstract][Full Text] [Related]
39. Cognitive performance amongst recreational users of "ecstasy".
Rodgers J
Psychopharmacology (Berl); 2000 Jul; 151(1):19-24. PubMed ID: 10958112
[TBL] [Abstract][Full Text] [Related]
40. Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or 'ecstasy': evidence for cognitive impairment.
Bhattachary S; Powell JH
Psychol Med; 2001 May; 31(4):647-58. PubMed ID: 11352367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
